STALEY CAPITAL ADVISERS’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-32,894
Closed -$850K 168
2017
Q2
$850K Buy
+32,894
New +$850K 0.07% 84